Blood for C/S (Single Bottle) Pead at Chughtai Lab Pakistan
Book at Chughtai Lab · Lahore, Pakistan
Book this test
Blood for C/S (Single Bottle) Pead at Chughtai Lab
The Blood for C/S (Single Bottle) Pead at Chughtai Lab is a highly specialized, life-saving diagnostic laboratory investigation designed specifically for pediatric patients. This test, which stands for Blood Culture and Sensitivity (Single Bottle, Pediatric), is utilized by clinicians to detect the presence of pathogenic microorganisms such as bacteria or fungi in the bloodstream of infants, toddlers, and children. Bloodstream infections in pediatric populations, including bacteremia and septicemia, are medical emergencies that require rapid identification and targeted therapeutic intervention. Because children have significantly lower circulating blood volumes compared to adults, standard adult culture bottles are unsuitable. The pediatric single-bottle system is engineered to optimize the recovery of pathogens from small volume blood specimens, typically ranging from 0.5 mL to 4 mL, ensuring diagnostic accuracy without compromising the hematological safety of the young patient.
The test operates on advanced automated continuous-monitoring blood culture technology. Once the pediatric blood sample is inoculated into the specialized culture bottle containing nutrient-rich broth and charcoal or polymeric beads (which neutralize circulating antibiotics), it is placed in an automated incubator. The system continuously monitors the bottle for carbon dioxide production, a direct byproduct of microbial metabolism. If growth is detected, the instrument flags the sample as positive, prompting immediate Gram staining and subculturing onto solid media for organism identification and antimicrobial susceptibility testing (AST). The primary diagnostic value of this test lies in its ability to not only confirm a bloodstream infection but also to provide a definitive susceptibility profile, allowing pediatricians to transition from broad-spectrum empiric therapy to precise, targeted antibiotic treatment, thereby improving clinical outcomes and reducing the risk of antimicrobial resistance.
Clinical Procedure: What to Expect
Patient Preparation
Preparing a pediatric patient for a Blood for C/S (Single Bottle) Pead at Chughtai Lab requires careful clinical coordination and parental support. Unlike many routine blood tests, fasting is not required for a blood culture. Parents should ensure the child is well-hydrated, as this makes venipuncture easier and less stressful. It is critical to inform the phlebotomist or laboratory staff if the child is currently taking any antibiotics or has recently completed a course, as circulating antibiotics can inhibit microbial growth in the culture medium, potentially leading to false-negative results. While the pediatric culture bottles contain specialized resins to neutralize antibiotics, providing a complete clinical history remains essential. Parents are encouraged to comfort their child and explain the procedure in age-appropriate terms to alleviate anxiety, which helps prevent vasoconstriction and facilitates a smoother sample collection process.
During the Procedure
The collection of a pediatric blood culture is a highly precise procedure that prioritizes both sterile technique and patient comfort. The phlebotomist at Chughtai Lab first identifies the optimal venipuncture site, usually the antecubital fossa or a vein on the back of the hand. Because skin contamination is the leading cause of false-positive blood cultures, rigorous skin antisepsis is performed. The site is cleansed using an appropriate pediatric-safe antiseptic, such as chlorhexidine gluconate or isopropyl alcohol, and allowed to dry completely. A sterile needle is inserted, and the precise volume of blood required for the pediatric bottle (usually 1 to 3 mL) is drawn directly into the syringe or culture bottle. Once collected, gentle pressure is applied to the puncture site with a sterile cotton ball, and a pediatric-friendly bandage is applied. The bottle is immediately labeled with the patient’s unique identifiers and transported to the microbiology department for automated incubation.
When is a Blood for C/S (Single Bottle) Pead Performed?
Neonatal Sepsis and Suspected Bacteremia
Neonatal sepsis is a critical, life-threatening condition in newborns that presents with subtle, non-specific clinical signs. Pediatricians urgently request a Blood for C/S (Single Bottle) Pead when a neonate exhibits symptoms such as temperature instability (hypothermia or hyperthermia), poor feeding, lethargy, hypotonia, or respiratory distress. Because a newborn’s immune system is immature, localized infections can rapidly progress to systemic bacteremia. This test is vital for confirming the presence of pathogens like Group B Streptococcus or Escherichia coli, enabling immediate targeted antimicrobial therapy to prevent severe complications, including septic shock and multi-organ failure.
Pyrexia of Unknown Origin (PUO) in Children
Pyrexia of Unknown Origin (PUO) in pediatric patients refers to a prolonged fever that lacks an obvious source after initial clinical evaluation. When a child presents with a persistent fever of 38°C (100.4°F) or higher lasting for several days without localized symptoms, physicians order a pediatric blood culture. This investigation helps differentiate between viral illnesses, which are self-limiting, and occult bacterial infections, such as typhoid fever (Salmonella enterica) or occult bacteremia, which require specific, prolonged antibiotic regimens to resolve completely.
Severe Localized Infections with Systemic Spread
Children suffering from severe localized infections, such as complicated pneumonia, osteomyelitis, septic arthritis, or severe urinary tract infections, are at high risk for hematogenous dissemination. If a child with a localized infection develops systemic symptoms like high-grade fever, chills, rapid heart rate (tachycardia), or tachypnea, a Blood for C/S (Single Bottle) Pead is indicated. Identifying the causative pathogen in the blood confirms systemic involvement and guides the selection of systemic intravenous antibiotics capable of penetrating the target tissues effectively.
Monitoring Post-Operative or Immunocompromised Pediatric Patients
Pediatric patients undergoing chemotherapy, those with congenital or acquired immunodeficiencies, or children recovering from major surgical procedures are highly susceptible to opportunistic bloodstream infections. In these vulnerable populations, even a mild fever or a subtle change in clinical status can indicate a severe infection. Clinicians frequently utilize the pediatric blood culture test to monitor these patients closely, ensuring that any bloodstream pathogen is identified at the earliest possible stage, allowing for aggressive, targeted therapy before the infection becomes overwhelming.
Unexplained Lethargy and Poor Feeding in Infants
Infants cannot articulate their symptoms, and severe infections often manifest solely as behavioral changes. When an infant exhibits unexplained, persistent lethargy, extreme irritability, or a sudden refusal to feed, it warrants immediate medical evaluation. Because these symptoms can be the early clinical presentation of systemic bacteremia or meningitis, pediatricians routinely include a Blood for C/S (Single Bottle) Pead in the diagnostic workup to rule out or confirm a systemic bacterial etiology, ensuring prompt and appropriate pediatric intensive care if required.
What Does a Blood for C/S (Single Bottle) Pead Detect?
The Blood for C/S (Single Bottle) Pead is designed to detect a wide spectrum of clinically significant pediatric pathogens and provide critical susceptibility data. The primary findings and parameters detected by this test include:
- Gram-Positive Bacterial Pathogens: Detection of organisms such as Streptococcus pneumoniae, Staphylococcus aureus, and Streptococcus pyogenes.
- Gram-Negative Bacterial Pathogens: Identification of Gram-negative rods including Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Salmonella enterica (serovars Typhi and Paratyphi).
- Neonatal Pathogens: Detection of Group B Streptococcus (GBS) and Listeria monocytogenes, which are common causes of early-onset neonatal sepsis.
- Fungal Pathogens: Identification of yeast species such as Candida albicans and non-albicans Candida species in immunocompromised pediatric patients.
- Gram Stain Morphology: Rapid preliminary identification of the organism’s shape and staining characteristics (e.g., Gram-positive cocci in chains, Gram-negative bacilli) within hours of a positive culture flag.
- Antimicrobial Susceptibility Profile: Determination of which specific antibiotics are effective (Sensitive), moderately effective (Intermediate), or ineffective (Resistant) against the isolated pathogen.
- Minimum Inhibitory Concentration (MIC): Quantitative measurement of the lowest concentration of an antimicrobial agent that prevents visible growth of the pathogen.
- Methicillin-Resistant Staphylococcus aureus (MRSA): Detection of resistance to methicillin/oxacillin, indicating the presence of a highly resistant staphylococcal strain.
- Extended-Spectrum Beta-Lactamase (ESBL) Production: Identification of Gram-negative bacteria that produce enzymes rendering them resistant to most beta-lactam antibiotics.
- Carbapenem-Resistant Enterobacteriaceae (CRE): Detection of highly resistant bacterial strains that require specialized, last-resort antibiotic therapies.
- Skin Flora Contamination: Identification of common skin contaminants such as Coagulase-Negative Staphylococci (CoNS), Cutibacterium acnes, or Micrococcus species, which may indicate improper skin preparation during venipuncture rather than a true infection.
- Time to Positivity (TTP): The duration from the start of incubation to the detection of microbial growth, which can provide clinical clues regarding the bacterial load and severity of infection.
- Polymicrobial Infection: Rare detection of more than one pathogen in the bloodstream, indicating a complex, multi-organism infection.
- Anaerobic Organisms: Though less common in pediatric single-bottle systems, certain anaerobic pathogens can occasionally be recovered if clinical conditions favor their growth.
- Fastidious Organisms: Detection of slow-growing or nutritionally demanding bacteria such as Haemophilus influenzae or Neisseria meningitidis.
Turnaround Time and Report Access at Chughtai Lab
At Chughtai Lab, the reporting process for a Blood for C/S (Single Bottle) Pead is structured to provide critical clinical information as rapidly as possible. Because bacterial growth is a biological process, the timeline is divided into preliminary and final reports. The automated blood culture system continuously monitors the sample; if growth is detected, a preliminary report containing the Gram stain results is generated within 12 to 24 hours. This initial finding is immediately communicated to the referring physician, as it provides the first clue to the nature of the pathogen. The final culture report, which includes the definitive identification of the organism and its complete antimicrobial susceptibility profile, is typically completed within 48 to 72 hours. Chughtai Lab offers convenient digital access to these reports. Patients and healthcare providers can view, download, and print reports online through the official Chughtai Lab website, the dedicated Chughtai Lab mobile application, or receive them directly via WhatsApp, ensuring rapid clinical decision-making when time is of the essence.
Blood for C/S (Single Bottle) Pead Findings Overview
| Structure / Parameter Evaluated | Normal Findings | Possible Abnormal Findings |
|---|---|---|
| Microbial Growth | No growth detected after 5 days of incubation | Growth of pathogenic bacteria or fungi detected |
| Gram Stain (Preliminary) | No organisms seen | Presence of Gram-positive cocci, Gram-negative bacilli, or yeast cells |
| Pathogen Identification | Sterile blood specimen | Isolation of specific pathogens (e.g., S. pneumoniae, S. typhi, E. coli) |
| Antimicrobial Susceptibility | Not applicable (no growth) | Detailed profile indicating Sensitivity (S) or Resistance (R) to tested antibiotics |
| Time to Positivity (TTP) | No growth flagged | Rapid growth detection (e.g., <12-24 hours), often indicating high bacterial load |
| Contamination Indicator | No growth | Isolation of skin flora (e.g., CoNS) in a single bottle, suggesting contamination |
| Fungal Evaluation | No fungal elements isolated | Detection of Candida species or other clinically significant yeasts |
Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.
Why Choose Chughtai Lab for Blood for C/S (Single Bottle) Pead?
- Experienced Healthcare Professionals: Chughtai Lab employs highly trained pediatric phlebotomists who specialize in drawing blood from infants and children with minimal discomfort.
- Patient-Focused Care: The laboratory environment is designed to be child-friendly, reducing anxiety for young patients and their parents during sample collection.
- Quality Diagnostic Services: Chughtai Lab utilizes state-of-the-art automated blood culture systems that provide continuous monitoring for rapid pathogen detection.
- Professional Reporting: Accurate, detailed, and clinically actionable reports are reviewed and signed by consultant microbiologists and pathologists.
- Modern Diagnostic Approach: The microbiology department follows international guidelines (such as CLSI) to ensure precise antimicrobial susceptibility testing.
- Comfortable Environment: Clean, sterile, and welcoming collection centers across Pakistan ensure a safe diagnostic experience.
- Convenient Location: With a vast network of collection centers nationwide, parents can easily find a Chughtai Lab facility nearby.
- Commitment to Accurate Diagnosis: Chughtai Lab maintains rigorous internal and external quality control protocols to ensure the highest level of diagnostic reliability.